(Q37650556)

21 August 2017

1 reference

title

Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint (English)

1 reference

21 August 2017

1 reference

Helge L Waldum

1

1 reference

21 August 2017

Gunnar Qvigstad

2

1 reference

21 August 2017

Reidar Fossmark

3

1 reference

21 August 2017

Per M Kleveland

4

1 reference

21 August 2017

Arne K Sandvik

5

1 reference

21 August 2017

publication date

1 April 2010

1 reference

Scandinavian Journal of Gastroenterology

21 August 2017

published in

1 reference

21 August 2017

volume

45

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

389-394

1 reference

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Marked increase in gastric acid secretory capacity after omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rebound hypersecretion after inhibition of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Gastrin-histamine sequence in the regulation of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

MOBILIZATION AND FORMATION OF HISTAMINE IN THE GASTRIC MUCOSA AS RELATED TO ACID SECRETION.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Histamine release by gastric stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Histamine and the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

The CCK-2 receptor is located on the ECL cell, but not on the parietal cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

The enterochromaffin-like (ECL) cell. Physiological and pathophysiological role

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Maximal histalog test in control subjects and patients with peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Genome sequence of the Brown Norway rat yields insights into mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Self-replication of enterochromaffin-like cells in the mouse stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Cell kinetics of slow renewing cell populations in mice stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Cimetidine in the treatment of active duodenal and prepyloric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Maintenance treatment of recurrent peptic ulcer by cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Maximum acid output and risk of peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rat gastric histamine release: a sensitive gastrin bioassay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rebound acid hypersecretion after long-term inhibition of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Helicobacter pylori and Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Biliary stricture: is dilatation an acceptable alternative to operation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Gastroesophageal reflux in duodenal ulcer patients before and after vagotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

Personal review: is profound acid inhibition safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903477348

10.3109/00365520903477348

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference